▶ 調査レポート

世界の経口ワクチン産業2020-2026

• 英文タイトル:Global Oral Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界の経口ワクチン産業2020-2026 / Global Oral Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3012542資料のイメージです。• レポートコード:D0MA3012542
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥539,000 (USD4,900)▷ お問い合わせ
  Multi User¥808,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,078,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、経口ワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、経口ワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他)、用途別市場規模(パブリック、プライベート)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・経口ワクチンの種類別市場2015-2026:ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他
・経口ワクチンの用途別市場2015-2026:パブリック、プライベート
・経口ワクチンの北米市場分析
・経口ワクチンのアジア市場分析
・経口ワクチンの中南米市場分析
・経口ワクチンの中東・アフリカ市場分析
・関連企業情報:Merck、GSK、Sanofi、Lanzhou Institute、Serum Institute、Valneva、Shanghai United Cell、Bibcol、PaxVax、Vabiotech、Tiantan Biological、EuBiologics、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
In 2019, the global Oral Vaccines market size was US$ 2323.3 million and is forecast to US$ 3775.1 million in 2026, growing at a CAGR of 7.1% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Oral Vaccines.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Oral Vaccines market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Oral Vaccines market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Oral Vaccines market. Readers of the report can become informed about current and future trends of the global Oral Vaccines market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Oral Vaccines markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Oral Vaccines market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Oral Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Oral Vaccines market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Oral Vaccines market is segmented into
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others

Market Segment by Application, the Oral Vaccines market is segmented into
Public
Private

This report includes the following manufacturers; we can also add the other companies as you want.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

The study objectives are:
To analyze and research the global Oral Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Oral Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oral Vaccines are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Oral Vaccines Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Oral Vaccines Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Rotavirus Vaccine
1.3.3 Cholera Vaccine
1.3.4 Oral Polio Vaccine
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Oral Vaccines Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Public
1.4.3 Private
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Oral Vaccines Revenue (2015-2026)
2.1.1 Global Oral Vaccines Revenue (2015-2026)
2.1.2 Global Oral Vaccines Sales (2015-2026)
2.2 Oral Vaccines Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Oral Vaccines Sales by Regions (2015-2020)
2.2.2 Global Oral Vaccines Revenue by Regions (2015-2020)
2.3 Global Top Oral Vaccines Regions (Countries) Ranking by Market Size
2.4 Oral Vaccines Industry Trends
2.4.1 Oral Vaccines Market Top Trends
2.4.2 Market Drivers
2.4.3 Oral Vaccines Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Oral Vaccines Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Oral Vaccines Manufacturers by Sales (2015-2020)
3.1.1 Global Oral Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Oral Vaccines Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Oral Vaccines Sales in 2019
3.2 Global Top Manufacturers Oral Vaccines by Revenue
3.2.1 Global Oral Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Oral Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2019)
3.4 Global Oral Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Oral Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Oral Vaccines Market
3.7 Key Manufacturers Oral Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Oral Vaccines Historic Market Review by Type (2015-2020)
4.1.2 Global Oral Vaccines Sales Market Share by Type (2015-2020)
4.1.3 Global Oral Vaccines Revenue Market Share by Type (2015-2020)
4.1.4 Oral Vaccines Price by Type (2015-2020)
4.1 Global Oral Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Oral Vaccines Sales Forecast by Type (2021-2026)
4.2.3 Global Oral Vaccines Revenue Forecast by Type (2021-2026)
4.2.4 Oral Vaccines Price Forecast by Type (2021-2026)

5 Global Oral Vaccines Market Size by Application
5.1 Global Oral Vaccines Historic Market Review by Application (2015-2020)
5.1.2 Global Oral Vaccines Sales Market Share by Application (2015-2020)
5.1.3 Global Oral Vaccines Revenue Market Share by Application (2015-2020)
5.1.4 Oral Vaccines Price by Application (2015-2020)
5.2 Global Oral Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Oral Vaccines Sales Forecast by Application (2021-2026)
5.2.3 Global Oral Vaccines Revenue Forecast by Application (2021-2026)
5.2.4 Oral Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Oral Vaccines Breakdown Data by Company
6.2 North America Oral Vaccines Breakdown Data by Type
6.3 North America Oral Vaccines Breakdown Data by Application
6.4 North America Oral Vaccines Breakdown Data by Countries
6.4.1 North America Oral Vaccines Sales by Countries
6.4.2 North America Oral Vaccines Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Oral Vaccines Breakdown Data by Company
7.2 Europe Oral Vaccines Breakdown Data by Type
7.3 Europe Oral Vaccines Breakdown Data by Application
7.4 Europe Oral Vaccines Breakdown Data by Countries
7.4.1 Europe Oral Vaccines Sales by Countries
7.4.2 Europe Oral Vaccines Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Oral Vaccines Breakdown Data by Company
8.2 Asia Pacific Oral Vaccines Breakdown Data by Type
8.3 Asia Pacific Oral Vaccines Breakdown Data by Application
8.4 Asia Pacific Oral Vaccines Breakdown Data by Regions
8.4.1 Asia Pacific Oral Vaccines Sales by Regions
8.4.2 Asia Pacific Oral Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Oral Vaccines Breakdown Data by Company
9.2 Latin America Oral Vaccines Breakdown Data by Type
9.3 Latin America Oral Vaccines Breakdown Data by Application
9.4 Latin America Oral Vaccines Breakdown Data by Countries
9.4.1 Latin America Oral Vaccines Sales by Countries
9.4.2 Latin America Oral Vaccines Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Oral Vaccines Breakdown Data by Type
10.2 Middle East and Africa Oral Vaccines Breakdown Data by Application
10.3 Middle East and Africa Oral Vaccines Breakdown Data by Countries
10.3.1 Middle East and Africa Oral Vaccines Sales by Countries
10.3.2 Middle East and Africa Oral Vaccines Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Merck Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Merck Oral Vaccines Products and Services
11.1.5 Merck SWOT Analysis
11.1.6 Merck Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.2.3 GSK Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 GSK Oral Vaccines Products and Services
11.2.5 GSK SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Sanofi Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Sanofi Oral Vaccines Products and Services
11.3.5 Sanofi SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Corporation Information
11.4.2 Lanzhou Institute Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Lanzhou Institute Oral Vaccines Products and Services
11.4.5 Lanzhou Institute SWOT Analysis
11.4.6 Lanzhou Institute Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Corporation Information
11.5.2 Serum Institute Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Serum Institute Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Serum Institute Oral Vaccines Products and Services
11.5.5 Serum Institute SWOT Analysis
11.5.6 Serum Institute Recent Developments
11.6 Valneva
11.6.1 Valneva Corporation Information
11.6.2 Valneva Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Valneva Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Valneva Oral Vaccines Products and Services
11.6.5 Valneva SWOT Analysis
11.6.6 Valneva Recent Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Corporation Information
11.7.2 Shanghai United Cell Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Shanghai United Cell Oral Vaccines Products and Services
11.7.5 Shanghai United Cell SWOT Analysis
11.7.6 Shanghai United Cell Recent Developments
11.8 Bibcol
11.8.1 Bibcol Corporation Information
11.8.2 Bibcol Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Bibcol Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Bibcol Oral Vaccines Products and Services
11.8.5 Bibcol SWOT Analysis
11.8.6 Bibcol Recent Developments
11.9 PaxVax
11.9.1 PaxVax Corporation Information
11.9.2 PaxVax Business Overview and Total Revenue (2019 VS 2018)
11.9.3 PaxVax Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 PaxVax Oral Vaccines Products and Services
11.9.5 PaxVax SWOT Analysis
11.9.6 PaxVax Recent Developments
11.10 Vabiotech
11.10.1 Vabiotech Corporation Information
11.10.2 Vabiotech Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Vabiotech Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Vabiotech Oral Vaccines Products and Services
11.10.5 Vabiotech SWOT Analysis
11.10.6 Vabiotech Recent Developments
11.11 Tiantan Biological
11.11.1 Tiantan Biological Corporation Information
11.11.2 Tiantan Biological Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Tiantan Biological Oral Vaccines Products and Services
11.11.5 Tiantan Biological SWOT Analysis
11.11.6 Tiantan Biological Recent Developments
11.12 EuBiologics
11.12.1 EuBiologics Corporation Information
11.12.2 EuBiologics Business Overview and Total Revenue (2019 VS 2018)
11.12.3 EuBiologics Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 EuBiologics Oral Vaccines Products and Services
11.12.5 EuBiologics SWOT Analysis
11.12.6 EuBiologics Recent Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Corporation Information
11.13.2 Panacea Biotec Ltd Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Panacea Biotec Ltd Oral Vaccines Products and Services
11.13.5 Panacea Biotec Ltd SWOT Analysis
11.13.6 Panacea Biotec Ltd Recent Developments
11.14 Bio-Med
11.14.1 Bio-Med Corporation Information
11.14.2 Bio-Med Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Bio-Med Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Bio-Med Oral Vaccines Products and Services
11.14.5 Bio-Med SWOT Analysis
11.14.6 Bio-Med Recent Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.15.2 Halfkin Bio-Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Products and Services
11.15.5 Halfkin Bio-Pharmaceuticals SWOT Analysis
11.15.6 Halfkin Bio-Pharmaceuticals Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Oral Vaccines Sales Channels
12.2.2 Oral Vaccines Distributors
12.3 Oral Vaccines Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Oral Vaccines Sales Forecast (2021-2026)
13.1.1 Global Oral Vaccines Sales Forecast by Regions (2021-2026)
13.1.2 Global Oral Vaccines Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Oral Vaccines Sales Forecast (2021-2026)
13.2.2 North America Oral Vaccines Revenue Forecast (2021-2026)
13.2.3 North America Oral Vaccines Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Oral Vaccines Sales Forecast (2021-2026)
13.3.2 Europe Oral Vaccines Revenue Forecast (2021-2026)
13.3.3 Europe Oral Vaccines Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Oral Vaccines Sales Forecast (2021-2026)
13.4.2 Asia Pacific Oral Vaccines Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Oral Vaccines Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Oral Vaccines Sales Forecast (2021-2026)
13.5.2 Latin America Oral Vaccines Revenue Forecast (2021-2026)
13.5.3 Latin America Oral Vaccines Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Oral Vaccines Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Oral Vaccines Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Oral Vaccines Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Oral Vaccines Key Market Segments
Table 2. Ranking of Global Top Oral Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Vaccines Market Size Growth Rate by Type 2021-2026 (M Doses) & (Million US$)
Table 4. Major Manufacturers of Rotavirus Vaccine
Table 5. Major Manufacturers of Cholera Vaccine
Table 6. Major Manufacturers of Oral Polio Vaccine
Table 7. Major Manufacturers of Others
Table 8. Global Oral Vaccines Market Share by Application 2019-2025 (M Doses)
Table 9. Global Oral Vaccines Market Size by Regions 2015-2020 (M Doses) & (Million US$)
Table 10. Global Oral Vaccines Sales by Regions 2015-2020 (M Doses)
Table 11. Global Oral Vaccines Sales Market Share by Regions 2015-2020
Table 12. Global Oral Vaccines Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Oral Vaccines Revenue Market Share by Regions 2015-2020
Table 14. Top Oral Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Oral Vaccines Key Drivers: Impact Analysis (2021-2026)
Table 17. Oral Vaccines Key Challenges
Table 18. Main Points Interviewed from Key Oral Vaccines Players: Views for Future
Table 19. Global Oral Vaccines Sales by Manufacturers (2015-2020) (M Doses)
Table 20. Global Oral Vaccines Sales Share by Manufacturers (2015-2020)
Table 21. Oral Vaccines Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Oral Vaccines Revenue Share by Manufacturers (2015-2020)
Table 23. Global Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2019)
Table 25. Key Manufacturers Oral Vaccines Average Selling Price (ASP) (2015-2020) (USD/K Doses)
Table 26. Key Manufacturers Oral Vaccines Plants/Factories Distribution
Table 27. Key Manufacturers Oral Vaccines Area Served
Table 28. Date of Key Manufacturers Enter into Oral Vaccines Market
Table 29. Key Manufacturers Oral Vaccines Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Rotavirus Vaccine Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 32. Global Cholera Vaccine Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 33. Global Oral Polio Vaccine Sales ana Revenue (2015-2020) (M Doses) & (Million US$)
Table 34. Global Others Sales ana Revenue (2015-2020) (M Doses) & (Million US$)
Table 35. Global Oral Vaccines Sales (M Doses) by Type (2015-2020)
Table 36. Global Oral Vaccines Sales Share by Type (2015-2020)
Table 37. Global Oral Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Oral Vaccines Price (M Doses) by Type (2015-2020)
Table 39. Global Oral Vaccines Sales (M Doses) by Type (2021-2026)
Table 40. Global Oral Vaccines Sales Share by Type (2021-2026)
Table 41. Global Oral Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Oral Vaccines Revenue Share by Type (2021-2026)
Table 43. Global Oral Vaccines Price (M Doses) by Type (2021-2026)
Table 44. Global Oral Vaccines Sales (M Doses) by Application (2015-2020)
Table 45. Global Oral Vaccines Sales Share by Application (2015-2020)
Table 46. Global Oral Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Oral Vaccines Price by Application 2015-2020 (USD/K Doses)
Table 48. Global Oral Vaccines Sales by Application (2015-2020) (M Doses)
Table 49. Global Oral Vaccines Sales Share by Application (2015-2020)
Table 50. Global Oral Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Oral Vaccines Revenue Share by Application (2021-2026)
Table 52. Global Oral Vaccines Price (M Doses) by Application (2021-2026)
Table 53. North America Oral Vaccines Sales by Company (2015-2020) (M Doses)
Table 54. North America Oral Vaccines Sales Market Share by Company (2015-2020)
Table 55. North America Oral Vaccines Sales by Type (2015-2020) (M Doses)
Table 56. North America Oral Vaccines Sales Market Share by Type (2015-2020)
Table 57. North America Oral Vaccines Sales by Application (2015-2020) (M Doses)
Table 58. North America Oral Vaccines Sales Market Share by Application (2015-2020)
Table 59. North America Oral Vaccines Sales by Countries (2015-2020) (M Doses)
Table 60. North America Oral Vaccines Sales Market Share by Countries (2015-2020)
Table 61. North America Oral Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Oral Vaccines Revenue Market Share by Countries (2015-2020)
Table 63. Europe Oral Vaccines Sales by Company (2015-2020) (M Doses)
Table 64. Europe Oral Vaccines Sales Market Share by Company (2015-2020)
Table 65. Europe Oral Vaccines Sales by Type (2015-2020) (M Doses)
Table 66. Europe Oral Vaccines Sales Market Share by Type (2015-2020)
Table 67. Europe Oral Vaccines Sales by Application (2015-2020) (M Doses)
Table 68. Europe Oral Vaccines Sales Market Share by Application (2015-2020)
Table 69. Europe Oral Vaccines Sales by Countries (2015-2020) (M Doses)
Table 70. Europe Oral Vaccines Sales Market Share by Countries (2015-2020)
Table 71. Europe Oral Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Oral Vaccines Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Oral Vaccines Sales by Regions (2015-2020) (M Doses)
Table 74. Asia Pacific Oral Vaccines Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Oral Vaccines Sales by Type (2015-2020) (M Doses)
Table 76. Asia Pacific Oral Vaccines Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Oral Vaccines Sales by Application (2015-2020) (M Doses)
Table 78. Asia Pacific Oral Vaccines Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Oral Vaccines Sales by Countries (2015-2020) (M Doses)
Table 80. Asia Pacific Oral Vaccines Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Oral Vaccines Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Oral Vaccines Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Oral Vaccines Sales by Company (2015-2020) (M Doses)
Table 84. Latin America Oral Vaccines Sales Market Share by Company (2015-2020)
Table 85. Latin America Oral Vaccines Sales by Type (2015-2020) (M Doses)
Table 86. Latin America Oral Vaccines Sales Market Share by Type (2015-2020)
Table 87. Latin America Oral Vaccines Sales by Application (2015-2020) (M Doses)
Table 88. Latin America Oral Vaccines Sales Market Share by Application (2015-2020)
Table 89. Latin America Oral Vaccines Sales by Countries (2015-2020) (M Doses)
Table 90. Latin America Oral Vaccines Sales Market Share by Countries (2015-2020)
Table 91. Latin America Oral Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Oral Vaccines Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Oral Vaccines Sales by Type (2015-2020) (M Doses)
Table 94. Middle East and Africa Oral Vaccines Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Oral Vaccines Sales by Application (2015-2020) (M Doses)
Table 96. Middle East and Africa Oral Vaccines Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Oral Vaccines Sales by Countries (2015-2020) (M Doses)
Table 98. Middle East and Africa Oral Vaccines Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Oral Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Oral Vaccines Revenue Market Share by Countries (2015-2020)
Table 101. Merck Company Details
Table 102. Merck Description and Business Overview
Table 103. Merck Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 104. Merck Oral Vaccines Sales Growth Rate (2015-2020)
Table 105. Merck Oral Vaccines Sales Market Share in Global Market
Table 106. Merck Recent Development
Table 107. GSK Company Details
Table 108. GSK Description and Business Overview
Table 109. GSK Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 110. GSK Oral Vaccines Sales Growth Rate (2015-2020)
Table 111. GSK Oral Vaccines Sales Market Share in Global Market
Table 112. GSK Recent Development
Table 113. Sanofi Company Details
Table 114. Sanofi Description and Business Overview
Table 115. Sanofi Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 116. Sanofi Oral Vaccines Sales Growth Rate (2015-2020)
Table 117. Sanofi Oral Vaccines Sales Market Share in Global Market
Table 118. Sanofi Recent Development
Table 119. Lanzhou Institute Company Details
Table 120. Lanzhou Institute Description and Business Overview
Table 121. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 122. Lanzhou Institute Oral Vaccines Sales Growth Rate (2015-2020)
Table 123. Lanzhou Institute Oral Vaccines Sales Market Share in Global Market
Table 124. Lanzhou Institute Recent Development
Table 125. Serum Institute Company Details
Table 126. Serum Institute Description and Business Overview
Table 127. Serum Institute Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 128. Serum Institute Oral Vaccines Sales Growth Rate (2015-2020)
Table 129. Serum Institute Oral Vaccines Sales Market Share in Global Market
Table 130. Serum Institute Recent Development
Table 131. Valneva Company Details
Table 132. Valneva Description and Business Overview
Table 133. Valneva Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 134. Valneva Oral Vaccines Sales Growth Rate (2015-2020)
Table 135. Valneva Oral Vaccines Sales Market Share in Global Market
Table 136. Valneva Recent Development
Table 137. Shanghai United Cell Company Details
Table 138. Shanghai United Cell Description and Business Overview
Table 139. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 140. Shanghai United Cell Oral Vaccines Sales Growth Rate (2015-2020)
Table 141. Shanghai United Cell Oral Vaccines Sales Market Share in Global Market
Table 142. Shanghai United Cell Recent Development
Table 143. Bibcol Company Details
Table 144. Bibcol Description and Business Overview
Table 145. Bibcol Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 146. Bibcol Oral Vaccines Sales Growth Rate (2015-2020)
Table 147. Bibcol Oral Vaccines Sales Market Share in Global Market
Table 148. Bibcol Recent Development
Table 149. PaxVax Company Details
Table 150. PaxVax Description and Business Overview
Table 151. PaxVax Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 152. PaxVax Oral Vaccines Sales Growth Rate (2015-2020)
Table 153. PaxVax Oral Vaccines Sales Market Share in Global Market
Table 154. PaxVax Recent Development
Table 155. Vabiotech Company Details
Table 156. Vabiotech Description and Business Overview
Table 157. Vabiotech Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 158. Vabiotech Oral Vaccines Sales Growth Rate (2015-2020)
Table 159. Vabiotech Oral Vaccines Sales Market Share in Global Market
Table 160. Vabiotech Recent Development
Table 161. Tiantan Biological Company Details
Table 162. Tiantan Biological Description and Business Overview
Table 163. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 164. Tiantan Biological Oral Vaccines Sales Growth Rate (2015-2020)
Table 165. Tiantan Biological Oral Vaccines Sales Market Share in Global Market
Table 166. Tiantan Biological Recent Development
Table 167. EuBiologics Company Details
Table 168. EuBiologics Description and Business Overview
Table 169. EuBiologics Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 170. EuBiologics Oral Vaccines Sales Growth Rate (2015-2020)
Table 171. EuBiologics Oral Vaccines Sales Market Share in Global Market
Table 172. EuBiologics Recent Development
Table 173. Panacea Biotec Ltd Company Details
Table 174. Panacea Biotec Ltd Description and Business Overview
Table 175. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 176. Panacea Biotec Ltd Oral Vaccines Sales Growth Rate (2015-2020)
Table 177. Panacea Biotec Ltd Oral Vaccines Sales Market Share in Global Market
Table 178. Panacea Biotec Ltd Recent Development
Table 179. Bio-Med Company Details
Table 180. Bio-Med Description and Business Overview
Table 181. Bio-Med Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 182. Bio-Med Oral Vaccines Sales Growth Rate (2015-2020)
Table 183. Bio-Med Oral Vaccines Sales Market Share in Global Market
Table 184. Bio-Med Recent Development
Table 185. Halfkin Bio-Pharmaceuticals Company Details
Table 186. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 187. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 188. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales Growth Rate (2015-2020)
Table 189. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales Market Share in Global Market
Table 190. Halfkin Bio-Pharmaceuticals Recent Development
Table 191. Oral Vaccines Distributors List
Table 192. Oral Vaccines Customers List
Table 193. Global Oral Vaccines Sales Forecast 2021-2026 (M Doses) & (Million US$)
Table 194. Global Oral Vaccines Sales Forecast by Type 2021-2026 (M Doses)
Table 195. Global Oral Vaccines Sales Forecast by Application 2021-2026 (M Doses)
Table 196. Global Oral Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 197. Global Oral Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 198. North America Oral Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 199. North America Oral Vaccines Revenue Forecast by Countries 2021-2026
Table 200. Europe Oral Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 201. Europe Oral Vaccines Revenue Market Share Forecast by Countries 2021-2026
Table 202. Asia Pacific Oral Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 203. Asia Pacific Oral Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 204. Latin America Oral Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 205. Latin America Oral Vaccines Revenue Forecast by Countries 2021-2026 (Million US$)
Table 206. Middle East and Africa Oral Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 207. Middle East and Africa Oral Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Sales Market Shar by Type 2015-2026
Figure 3. Rotavirus Vaccine Figures
Figure 4. Cholera Vaccine Figures
Figure 5. Oral Polio Vaccine Figures
Figure 6. Others Figures
Figure 7. Global Oral Vaccines Sales Market Share by Application in 2019 & 2026
Figure 8. Public Use Case
Figure 9. Private Use Case
Figure 10. Oral Vaccines Report Years Considered
Figure 11. Global Oral Vaccines Market Size 2015-2026 (Million US$)
Figure 12. Global Oral Vaccines Sales 2015-2020 (M Doses)
Figure 13. Global Oral Vaccines Market Size Market Share by Regions 2015-2020
Figure 14. Global Oral Vaccines Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Oral Vaccines Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Vaccines Sales in 2019
Figure 18. Oral Vaccines Value Share by Manufacturers in 2019
Figure 19. Oral Vaccines Revenue Share by Manufacturers In 2019
Figure 20. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Oral Vaccines Revenue Share by Type (2015-2020)
Figure 22. Global Oral Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Oral Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Oral Vaccines Revenue Share by Application (2015-2020)
Figure 25. Global Oral Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Oral Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 28. Canada Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 29. Europe Oral Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 31. France Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 32. U.K. Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 33. Italy Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 34. Russia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 35. Asia Pacific Oral Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 37. Japan Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 38. South Korea Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 39. India Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Australia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 41. Taiwan Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 42. Indonesia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 43. Thailand Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 44. Malaysia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 45. Philippines Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 46. Vietnam Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 47. Latin America Oral Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Brazil Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 50. Argentina Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Middle East and Africa Oral Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 53. Saudi Arabia Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 54. U.A.E Oral Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 55. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Lanzhou Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Serum Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Shanghai United Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Bibcol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. PaxVax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Vabiotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. EuBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Panacea Biotec Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Halfkin Bio-Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Oral Vaccines Value Chain
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 73. North America Oral Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 74. North America Oral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Europe Oral Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 76. Europe Oral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Asia Pacific Oral Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 78. Asia Pacific Oral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 79. Latin America Oral Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 80. Latin America Oral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 81. Middle East and Africa Oral Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 82. Middle East and Africa Oral Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed